United States · FDA National Drug Code directory
VITRAKVI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50419-392_0e3ba6e7-af8d-4840-9409-a537a09e1263
- Product NDC
- 50419-392
- Form
- SOLUTION, CONCENTRATE
- Composition / generic term
- LAROTRECTINIB
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190726
- Source listing expiry
- 20271231
Source-listed ingredients
- LAROTRECTINIB — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 100 mL in 1 BOTTLE (50419-392-01) · 50419-392-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →